Eptastigmine restores the aged rat's normal cortical spectral power pattern

Area of Science:

• Neuroscience
• Pharmacology
• Gerontology

Background:

• Aging is associated with significant changes in electroencephalogram (EEG) spectral power.
• Specifically, older individuals exhibit increased slow-wave delta activity and decreased fast-wave alpha and beta activity.
• These EEG alterations correlate with cognitive decline.

Purpose of the Study:

• To investigate the efficacy of eptastigmine, a novel acetylcholinesterase inhibitor (AChEI).
• To determine if eptastigmine can reverse age-related changes in EEG spectral power in rats.
• To assess the potential of eptastigmine in mitigating age-associated cognitive decline.

Main Methods:

• Utilized electroencephalogram (EEG) recordings in young (4-6 months) and old (27-30 months) rats.
• Administered single oral doses of eptastigmine (0.5-4 mg kg(-1)) to rats.
• Measured changes in delta, alpha, and beta frequency bands of cortical spectral power.
• Assessed spontaneous motor activity using horizontal and vertical counts.

Main Results:

• Old rats showed significantly higher delta activity and lower alpha and beta activity compared to young rats.
• Eptastigmine treatment in old rats dose-dependently decreased delta activity and increased alpha and beta activity.
• Low-dose eptastigmine (0.5 mg kg(-1)) also reduced delta activity and increased beta activity in young rats.
• Eptastigmine did not significantly alter spontaneous motor activity in either age group at effective doses.

Conclusions:

• Eptastigmine effectively reverses age-related alterations in cortical EEG spectral power in rats.
• The drug normalizes the balance between slow and fast wave activities.
• These findings suggest eptastigmine as a potential therapeutic strategy for age-related cognitive decline.